Results 91 to 100 of about 1,716,389 (207)

Circulating vaccine-derived polioviruses: current state of knowledge

Bulletin of the World Health Organization, 2004
Within the past 4 years, poliomyelitis outbreaks associated with circulating vaccine-derived polioviruses (cVDPVs) have occurred in Hispaniola (2000-01), the Philippines (2001), and Madagascar (2001-02).
Kew Olen M., Wright Peter F., Agol Vadim I., Delpeyroux Francis, Shimizu Hiroyuki, Nathanson Neal, Pallansch Mark A.   +6 more
doaj  

Type 2 Poliovirus Detection After Global Withdrawal of Trivalent Oral Vaccine [PDF]

, 2018
Background Mass campaigns with oral poliovirus vaccine (OPV) have brought the world close to the eradication of wild poliovirus. However, to complete eradication, OPV must itself be withdrawn to prevent outbreaks of vaccine-derived poliovirus (VDPV ...
Blake, IM, Zaffran, Michel, Diop, Ousmane, Chenoweth, Paul, Grassly, Nicholas, Bandyopadhyay, Ananda, Pons Salort, Margarita, Molodecky, Natalia, Sutter, Roland   +8 more
core   +1 more source

Epidemiology and vaccination strategies against type-2 vaccine -derived poliovirus [PDF]

In 1988, the World Health Assembly passed a resolution to eradicate poliomyelitis, a disease which was endemic in 125 countries and paralyzed 350,000 children per year.
Macklin, GR
core   +1 more source

Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus.

PLoS ONE, 2016
BackgroundThe "gold standard" for assessing mucosal immunity after vaccination with poliovirus vaccines consists in measuring virus excretion in stool after challenge with oral poliovirus vaccine (OPV).
Ayan Dey, Natalie A Molodecky, Harish Verma, Prashant Sharma, Jae Seung Yang, Giulietta Saletti, Mohammad Ahmad, Sunil K Bahl, Thomas F Wierzba, Ranjan K Nandy, Jagadish M Deshpande, Roland W Sutter, Cecil Czerkinsky   +12 more
doaj   +1 more source

Polio eradication in Ghana: past, present, and future

Frontiers in Tropical Diseases
IntroductionGhana joined the Global Polio Eradication Initiative in 1996 to interrupt wild poliovirus transmission in the country. This was a collaborative effort by the Ghana Health Service (Disease Surveillance Department and the Expanded Program on ...
John Kofi Odoom, Dennis Odai Laryea, Nana Afia Asante Ntim, Keren Attiku, Michael Adjabeng, Ewurabena Oduma Duker, Comfort Nuamah Antwi, Emmanuel Gberbi, Isaac Baffoe-Nyarko, Patience Lartekai Adams, Angelina Evelyn Dickson, Jessica Dufie Boakye, Jude Yayra Mensah, Christabel Odoom, Sharon Ansong Bimpong, Deborah Odame, Gayheart Deladem Agboste, Nancy Odoom, Franklin Asiedu-Bekoe, Evangeline Obodai   +19 more
doaj   +1 more source

Biologicals [PDF]

According to manufacturers, inactivated poliovirus vaccines (IPVs) are freeze sensitive and require storage between 2\ub0C and 8\ub0C, whereas oral poliovirus vaccine requires storage at -20\u202f\ub0C.

core  

Certification of the industry reference standard for the specific activity of «BiVac polio» - live attenuated bivalent oral polio vaccine type 1 and 3

Биопрепараты: Профилактика, диагностика, лечение, 2018
The standardization and control of «BiVac polio» (live attenuated bivalent oral polio vaccine type 1 and 3) developed by M. P. Chumakov Institute of Poliomyelitis and Viral Encephalitides of the Russian Academy of Medical Sciences, called for ...
E. V. Karpova, A. D. Sangadzhieva, T. V. Mamontova, O. V. Fadeykina, R. A. Volkova, K. A. Sarkisyan, A. A. Movsesyants   +6 more
doaj  

Polio: Background and perspective on how international travel can be made safe against polio

Therapeutic Advances in Infectious Disease
International spread of polio continues to be a Public Health Emergency of International Concern since its declaration by the World Health Organization in 2014 and its reiteration in 2024.
Dhanya Dharmapalan, Thekkekara Jacob John, Robert Steinglass, Norbert Hirschhorn   +3 more
doaj   +1 more source

The Immunogenicity of Monovalent Oral Poliovirus Vaccine Type 1 (mOPV1) and Inactivated Poliovirus Vaccine (IPV) in the EPI Schedule of India

Background: In 2016, the Global Polio Eradication Initiative (GPEI) recommended the cessation of using type 2 oral poliovirus vaccine (OPV) and OPV, with countries having to switch from the trivalent to bivalent OPV (bOPV) with the addition of ...
T. Jacob John, Padmasani Venkat Ramanan, Lalitendu Mohanty, Shailesh D. Pawar, Sharad Agarkhedkar, Pradeep Haldar   +5 more
core   +1 more source

Costs and Benefits of Including Inactivated in Addition to Oral Poliovirus Vaccine in Outbreak Response After Cessation of Oral Poliovirus Vaccine Use

, 2017
Background: After stopping serotype 2–containing oral poliovirus vaccine use, serotype 2 poliovirus outbreaks may still occur and require outbreak response supplemental immunization activities (oSIAs).
Kimberly M. Thompson ScD, Kimberly M. Thompson, Radboud J. Duintjer Tebbens PhD, Radboud J. Duintjer Tebbens   +3 more
core   +1 more source